Michael Graffeo

Mike Graffeo is the CEO and co-founder of FluidForm, which uses 3D printing to build living human tissue to improve the treatment of disease. In over 20 years in the life sciences, Mike has brought four novel products through the FDA that have generated over $20 billion in sales in both startup and growth organizations. Throughout his career, he has worked on the forefront of medical technologies, translating highly complex products and clinical data into successful businesses, in the US and around the world. He is a graduate of Cornell University (B.S. Engineering Physics, M.Eng. Mechanical Engineering) and Harvard Business School (MBA), where he was a Baker Scholar.